, Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, vol.351, issue.9114, pp.1451-1467, 1998.

, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, vol.365, issue.9472, pp.1687-1717, 2005.

R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar, Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol Rev, vol.53, issue.1, pp.25-71, 2001.

M. J. Mourits, D. Vries, E. G. Willemse, P. H. , T. Hoor et al., Tamoxifen treatment and gynecologic side effects: a review, Obstet Gynecol, vol.97, issue.5, pp.855-866, 2001.

P. J. Goodwin, M. Ennis, K. I. Pritchard, M. Trudeau, and N. Hood, Risk of menopause during the first year after breast cancer diagnosis, J Clin Oncol, vol.17, issue.8, pp.2365-2370, 1999.

L. Osterberg and T. Blaschke, Adherence to medication, N Engl J Med, vol.353, issue.5, pp.487-497, 2005.

L. Fallowfield, A. Fleissig, R. Edwards, A. West, T. J. Powles et al., Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials, J Clin Oncol, vol.19, issue.7, pp.1885-1892, 2001.

R. Day, P. A. Ganz, J. P. Costantino, W. M. Cronin, D. L. Wickerham et al., Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Clin Oncol, vol.17, issue.9, pp.2659-2669, 1999.

D. M. Waterhouse, K. A. Calzone, C. Mele, and D. E. Brenner, Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring, J Clin Oncol, vol.11, issue.6, pp.1189-1197, 1993.

S. Demissie, R. A. Silliman, and T. L. Lash, Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women, J Clin Oncol, vol.19, issue.2, pp.322-328, 2001.

V. Murthy, G. Bharia, and R. Sarin, Tamoxifen noncompliance: does it matter?, Lancet Oncol, vol.3, issue.11, p.654, 2002.

A. H. Partridge, P. S. Wang, E. P. Winer, and J. Avorn, Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer, J Clin Oncol, vol.21, issue.4, pp.602-606, 2003.

E. A. Grunfeld, M. S. Hunter, P. Sikka, and S. Mittal, Adherence beliefs among breast cancer patients taking tamoxifen, Patient Educ Couns, vol.59, issue.1, pp.97-102, 2005.

A. K. Fink, J. Gurwitz, W. Rakowski, E. Guadagnoli, and R. A. Silliman, Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer, J Clin Oncol, vol.22, issue.16, pp.3309-3315, 2004.

T. L. Lash, M. P. Fox, J. L. Westrup, A. K. Fink, and R. A. Silliman, Adherence to tamoxifen over the five-year course, Breast Cancer Res Treat, vol.99, issue.2, pp.215-220, 2006.

K. L. Kahn, E. C. Schneider, J. L. Malin, J. L. Adams, and A. M. Epstein, Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use, Med Care, vol.45, issue.5, pp.431-439, 2007.

T. I. Barron, R. Connolly, K. Bennett, J. Feely, and M. J. Kennedy, Early discontinuation of tamoxifen: a lesson for oncologists, Cancer, vol.109, issue.5, pp.832-839, 2007.

C. Owusu, D. S. Buist, T. S. Field, T. L. Lash, S. S. Thwin et al., Predictors of tamoxifen discontinuation among older women with estrogen receptorpositive breast cancer, J Clin Oncol, vol.26, issue.4, pp.549-555, 2008.

M. Baum, A. Buzdar, J. Cuzick, J. Forbes, J. Houghton et al., Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with earlystage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses, Cancer, vol.98, issue.9, pp.1802-1810, 2003.

A. Howell, Adjuvant aromatase inhibitors for breast cancer, Lancet, vol.366, issue.9484, pp.431-433, 2005.

L. Atkins and L. Fallowfield, Intentional and non-intentional non-adherence to medication amongst breast cancer patients, Eur J Cancer, vol.42, issue.14, pp.2271-2276, 2006.

N. Britten, Patients' ideas about medicines: a qualitative study in a general practice population, Br J Gen Pract, vol.44, issue.387, pp.465-468, 1994.

J. L. Donovan and D. R. Blake, Patient non-compliance: deviance or reasoned decision-making?, Soc Sci Med, vol.34, issue.5, pp.507-513, 1992.

R. Horne and J. Weinman, Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness, J Psychosom Res, vol.47, issue.6, pp.555-567, 1999.

B. Glaser, The Discovery of Grounded Theory: Strategies for Qualitative Research, 1967.

C. Pope and N. Mays, Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research, BMJ, vol.311, issue.6996, pp.42-45, 1995.

K. Charmaz, Discovering' chronic illness: using grounded theory, Soc Sci Med, vol.30, issue.11, pp.1161-1172, 1990.

M. S. Hunter, I. O'dea, and N. Britten, Decision-making and hormone replacement therapy: a qualitative analysis, Soc Sci Med, vol.45, issue.10, pp.1541-1548, 1997.

R. B. Haynes, H. P. Mcdonald, and A. X. Garg, Helping patients follow prescribed treatment: clinical applications, JAMA, vol.288, issue.22, pp.2880-2883, 2002.

U. Veronesi, S. Von-kleist, R. K. Costa, A. Delvaux, N. Freilich et al., Caring about women and cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers, Eur J Cancer, vol.35, issue.12, pp.1667-1675, 1999.

B. Thewes, B. Meiser, A. Taylor, K. A. Phillips, S. Pendlebury et al., Fertility-and menopauserelated information needs of younger women with a diagnosis of early breast cancer, J Clin Oncol, vol.23, issue.22, pp.5155-5165, 2005.

R. Mcgurk, L. Fallowfield, and Z. Winters, Information provision for patients by breast cancer teams about the side-effects of hormone treatments, Eur J Cancer, vol.42, issue.12, pp.1760-1767, 2006.

B. Thewes, B. Meiser, J. Rickard, and M. Friedlander, The fertility-and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study, Psycho-Oncology, vol.12, issue.5, pp.500-511, 2003.

D. Dimatteo, Achieving Patient Compliance, 1982.

E. E. Bartlett, M. Grayson, R. Barker, D. M. Levine, A. Golden et al., The effects of physician communications skills on patient satisfaction; recall, and adherence, J Chronic Dis, vol.37, issue.9, pp.755-764, 1984.

R. Leonard, L. Lee, and M. E. Harrison, Impact of sideeffects associated with endocrine treatments for advanced breast cancer: clinicians and patients perceptions, The Breast, vol.5, pp.259-264, 1996.

M. Lock, Contested meanings of the menopause, Lancet, vol.337, issue.8752, pp.1270-1272, 1991.

L. Savage, Researchers wonder why high-risk women are not taking chemoprevention drugs, J Natl Cancer Inst, vol.99, issue.12, pp.913-914, 2007.